Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Glioblastoma D005909 27 associated lipids
Endotoxemia D019446 27 associated lipids
Insulinoma D007340 28 associated lipids
Neuralgia D009437 28 associated lipids
Proteinuria D011507 30 associated lipids
Acute Lung Injury D055371 33 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Anaphylaxis D000707 35 associated lipids
Acne Vulgaris D000152 35 associated lipids
Heart Failure D006333 36 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Adenoma D000236 40 associated lipids
Arthritis D001168 41 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Psoriasis D011565 47 associated lipids
Asthma D001249 52 associated lipids
Nerve Degeneration D009410 53 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Pain D010146 64 associated lipids
Reperfusion Injury D015427 65 associated lipids
Neuroblastoma D009447 66 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Melanoma D008545 69 associated lipids
Colitis D003092 69 associated lipids
Coronary Disease D003327 70 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Leukemia D007938 74 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Atherosclerosis D050197 85 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Insulin Resistance D007333 99 associated lipids
Weight Gain D015430 101 associated lipids
Glioma D005910 112 associated lipids
Hypertension D006973 115 associated lipids
Inflammation D007249 119 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Edema D004487 152 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Adenocarcinoma D000230 166 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Kulinski JM et al. Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function. 2016 Eur. J. Pharmacol. pmid:25941085
Lei YC et al. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure. 2016 World J. Gastroenterol. pmid:28028363
Al Fadel F et al. Involvement of Sphingosine 1-Phosphate in Palmitate-Induced Non-Alcoholic Fatty Liver Disease. 2016 Cell. Physiol. Biochem. pmid:28006772
Bigaud M et al. Pathophysiological Consequences of a Break in S1P1-Dependent Homeostasis of Vascular Permeability Revealed by S1P1 Competitive Antagonism. 2016 PLoS ONE pmid:28005953
Kasbi-Chadli F et al. Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet. 2016 Eur J Nutr pmid:25787885
Gharbaran R Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma. 2016 Tumour Biol. pmid:27317256
Higashi K et al. Sphingosine-1-phosphate/S1PR2-mediated signaling triggers Smad1/5/8 phosphorylation and thereby induces Runx2 expression in osteoblasts. 2016 Bone pmid:27612439
Sasset L et al. Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis. 2016 Trends Endocrinol. Metab. pmid:27562337
Roviezzo F et al. Disodium cromoglycate inhibits asthma-like features induced by sphingosine-1-phosphate. 2016 Pharmacol. Res. pmid:27713021
Hemdan NY et al. Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis. 2016 Eur. J. Immunol. pmid:27683081
Kemppainen K et al. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner. 2016 Cell. Signal. pmid:27634386
Custódio R et al. Characterization of secreted sphingosine-1-phosphate lyases required for virulence and intracellular survival of Burkholderia pseudomallei. 2016 Mol. Microbiol. pmid:27632710
Ebenezer DL et al. Targeting sphingosine-1-phosphate signaling in lung diseases. 2016 Pharmacol. Ther. pmid:27621206
Tsuchida J et al. Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis. 2016 J. Surg. Res. pmid:27621003
Chen W et al. Sphingosine 1-phosphate in metabolic syndrome (Review). 2016 Int. J. Mol. Med. pmid:27600830
Chen C et al. Polydatin attenuates AGEs-induced upregulation of fibronectin and ICAM-1 in rat glomerular mesangial cells and db/db diabetic mice kidneys by inhibiting the activation of the SphK1-S1P signaling pathway. 2016 Mol. Cell. Endocrinol. pmid:26948947
Rodvold JJ and Zanetti M Tumor microenvironment on the move and the Aselli connection. 2016 Sci Signal pmid:27353363
Harijith A et al. Hyperoxia-induced p47phox activation and ROS generation is mediated through S1P transporter Spns2, and S1P/S1P1&2 signaling axis in lung endothelium. 2016 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:27343196
Hernández-Coronado CG et al. Sphingosine-1-phosphate, regulated by FSH and VEGF, stimulates granulosa cell proliferation. 2016 Gen. Comp. Endocrinol. pmid:27342378
Chakrabarti SS et al. Ceramide and Sphingosine-1-Phosphate in Cell Death Pathways : Relevance to the Pathogenesis of Alzheimer's Disease. 2016 Curr Alzheimer Res pmid:27335046
Tsai HC and Han MH Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation. 2016 Drugs pmid:27318702
Yang Z et al. TGR5 activation suppressed S1P/S1P2 signaling and resisted high glucose-induced fibrosis in glomerular mesangial cells. 2016 Pharmacol. Res. pmid:27317945
Cantalupo A and Di Lorenzo A S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis. 2016 J. Pharmacol. Exp. Ther. pmid:27317800
Frej C et al. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons. 2016 J. Cell. Mol. Med. pmid:26990127
Pyne S et al. Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances. 2016 Prog. Lipid Res. pmid:26970273
Aoki M et al. Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential. 2016 Mediators Inflamm. pmid:26966342
Brinck JW et al. Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection. 2016 Arterioscler. Thromb. Vasc. Biol. pmid:26966278
Chawla S et al. S1P prophylaxis mitigates acute hypobaric hypoxia-induced molecular, biochemical, and metabolic disturbances: A preclinical report. 2016 IUBMB Life pmid:26959531
Vito CD et al. Platelet-derived sphingosine-1-phosphate and inflammation: from basic mechanisms to clinical implications. 2016 Platelets pmid:26950429
Chapurlat RD and Confavreux CB Novel biological markers of bone: from bone metabolism to bone physiology. 2016 Rheumatology (Oxford) pmid:26790456
Zhang Y et al. Ceramide Production Mediates Aldosterone-Induced Human Umbilical Vein Endothelial Cell (HUVEC) Damages. 2016 PLoS ONE pmid:26788916
Dillmann C et al. S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells. 2016 J. Immunol. pmid:26783340
Ghasemi R et al. Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage. 2016 Pharmacol. Res. pmid:26772814
Morel S et al. Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43. 2016 Cardiovasc. Res. pmid:26762268
Sundaram K et al. Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death. 2016 Biochem. J. pmid:26747710
Abu Khweek A et al. The Sphingosine-1-Phosphate Lyase (LegS2) Contributes to the Restriction of Legionella pneumophila in Murine Macrophages. 2016 PLoS ONE pmid:26741365
Realini N et al. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION. 2016 J. Biol. Chem. pmid:26553872
Campos LS et al. Filamin A Expression Negatively Regulates Sphingosine-1-Phosphate-Induced NF-κB Activation in Melanoma Cells by Inhibition of Akt Signaling. 2016 Mol. Cell. Biol. pmid:26552704
Cheng JC et al. Sphingosine-1-phosphate induces COX-2 expression and PGE2 production in human granulosa cells through a S1P1/3-mediated YAP signaling. 2016 Cell. Signal. pmid:26994820
Liu X et al. Transforming growth factor-β-sphingosine kinase 1/S1P signaling upregulates microRNA-21 to promote fibrosis in renal tubular epithelial cells. 2016 Exp. Biol. Med. (Maywood) pmid:26376826
Filipenko I et al. Upregulation of the S1P3 receptor in metastatic breast cancer cells increases migration and invasion by induction of PGE2 and EP2/EP4 activation. 2016 Biochim. Biophys. Acta pmid:27616330
Powell JA et al. Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia. 2017 Blood pmid:27956387
Miyabe C et al. A sphingosine 1-phosphate receptor agonist ameliorates animal model of vasculitis. 2017 Inflamm. Res. pmid:27942751
Williams PA et al. Alginate-Chitosan Hydrogels Provide a Sustained Gradient of Sphingosine-1-Phosphate for Therapeutic Angiogenesis. 2017 Ann Biomed Eng pmid:27904998
Mao-Draayer Y et al. The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases. 2017 Clin. Immunol. pmid:27890706
Lee MH et al. S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization. 2017 J. Lipid Res. pmid:27881715
Ruiz M et al. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1. 2017 Arterioscler. Thromb. Vasc. Biol. pmid:27879252
Barnawi J et al. Reduced DNA methylation of sphingosine-1 phosphate receptor 5 in alveolar macrophages in COPD: A potential link to failed efferocytosis. 2017 Respirology pmid:27868302
Frias MA et al. High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia. 2017 Eur. J. Clin. Invest. pmid:27861771
Fang V et al. Gradients of the signaling lipid S1P in lymph nodes position natural killer cells and regulate their interferon-γ response. 2017 Nat. Immunol. pmid:27841869
Wang R et al. Hepatic Stellate Cell Selective Disruption of Dynamin-2 GTPase Increases Murine Fibrogenesis through Up-Regulation of Sphingosine-1 Phosphate-Induced Cell Migration. 2017 Am. J. Pathol. pmid:27840081
Vogt D and Stark H Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism. 2017 Med Res Rev pmid:27480072
Olesch C et al. Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation. 2017 Mediators Inflamm. pmid:28848247
Egom EE et al. Determination of Sphingosine-1-Phosphate in Human Plasma Using Liquid Chromatography Coupled with Q-Tof Mass Spectrometry. 2017 Int J Mol Sci pmid:28820460
Swendeman SL et al. An engineered S1P chaperone attenuates hypertension and ischemic injury. 2017 Sci Signal pmid:28811382
Syed SN et al. S1P Provokes Tumor Lymphangiogenesis via Macrophage-Derived Mediators Such as IL-1 or Lipocalin-2. 2017 Mediators Inflamm. pmid:28804221
Doan NB et al. Acid ceramidase confers radioresistance to glioblastoma cells. 2017 Oncol. Rep. pmid:28765947
Arish M et al. Implication of sphingosine-1-phosphate signaling in diseases: molecular mechanism and therapeutic strategies. 2017 J. Recept. Signal Transduct. Res. pmid:28758826
Polzin A et al. Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease. 2017 J. Mol. Cell. Cardiol. pmid:28709768
Innamorati G et al. Pleiotropic effects of sphingosine-1-phosphate signaling to control human chorionic mesenchymal stem cell physiology. 2017 Cell Death Dis pmid:28703804
Bougault C et al. Involvement of sphingosine kinase/sphingosine 1-phosphate metabolic pathway in spondyloarthritis. 2017 Bone pmid:28684192
Tsai CH et al. Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression. 2017 Mol Oncol pmid:28672103
Schmidt KG et al. Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study. 2017 Front Immunol pmid:29033951
Xie Z et al. Targeting sphingosine-1-phosphate signaling for cancer therapy. 2017 Sci China Life Sci pmid:28623546
Yanagida K et al. Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1. 2017 Proc. Natl. Acad. Sci. U.S.A. pmid:28396408
Takahashi C et al. Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression. 2017 J. Atheroscler. Thromb. pmid:28321011
Vu TM et al. Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets. 2017 Nature pmid:29045386
Kurano M et al. Involvement of Band3 in the efflux of sphingosine 1-phosphate from erythrocytes. 2017 PLoS ONE pmid:28494002
Zeng Y Endothelial glycocalyx as a critical signalling platform integrating the extracellular haemodynamic forces and chemical signalling. 2017 J. Cell. Mol. Med. pmid:28211170
Sun XJ et al. Sphingosine-1-phosphate and its receptors in anti-neutrophil cytoplasmic antibody-associated vasculitis. 2017 Nephrol. Dial. Transplant. pmid:28206609
Janecke AR et al. Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications. 2017 Hum. Mutat. pmid:28181337
Moritz E et al. Reference intervals for serum sphingosine-1-phosphate in the population-based Study of Health in Pomerania. 2017 Clin. Chim. Acta pmid:28159438
Winkler MS et al. Sphingosine-1-Phosphate: A Potential Biomarker and Therapeutic Target for Endothelial Dysfunction and Sepsis? 2017 Shock pmid:27922551
Al-Jarallah A and Oriowo M The effect of sphingosine-1-phosphate on colonic smooth muscle contractility: Modulation by TNBS-induced colitis. 2017 PLoS ONE pmid:28493876
Chen T et al. Sphingosine-1 phosphate promotes intestinal epithelial cell proliferation via S1PR2. 2017 Front Biosci (Landmark Ed) pmid:27814635
Beider K et al. The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway. 2017 Clin. Cancer Res. pmid:27697999
Thieme M et al. Sphingosine-1-phosphate modulators in inflammatory skin diseases - lining up for clinical translation. 2017 Exp. Dermatol. pmid:27574180
Chang CH and Randolph GJ Sphingosine-1-Phosphate as the Lymphocyte's Ticket to Ride and Survive. 2017 Dev. Cell pmid:28633013
Fang R et al. Sphingosine 1-Phosphate Postconditioning Protects Against Myocardial Ischemia/reperfusion Injury in Rats via Mitochondrial Signaling and Akt-Gsk3β Phosphorylation. 2017 Arch. Med. Res. pmid:28625317
Rohrbach T et al. Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology. 2017 Crit. Rev. Biochem. Mol. Biol. pmid:28618839
Vijayan M et al. Sphingosine 1-Phosphate Lyase Enhances the Activation of IKKε To Promote Type I IFN-Mediated Innate Immune Responses to Influenza A Virus Infection. 2017 J. Immunol. pmid:28600291
White CR et al. High-Density Lipoprotein Regulation of Mitochondrial Function. 2017 Adv. Exp. Med. Biol. pmid:28551800
Dany M and Elston D Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa. 2017 J. Am. Acad. Dermatol. pmid:28551069
Mendoza A et al. Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. 2017 Nature pmid:28538737
Ma S et al. A Brain-Region-Specific Neural Pathway Regulating Germinal Matrix Angiogenesis. 2017 Dev. Cell pmid:28535372
Meshcheryakova A et al. Sphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential. 2017 Expert Opin. Ther. Targets pmid:28524744
Ko J et al. Sphingosine-1-Phosphate Mediates Fibrosis in Orbital Fibroblasts in Graves' Orbitopathy. 2017 Invest. Ophthalmol. Vis. Sci. pmid:28492873
Tafelmeier M et al. Mildly oxidized HDL decrease agonist-induced platelet aggregation and release of pro-coagulant platelet extracellular vesicles. 2017 J. Steroid Biochem. Mol. Biol. pmid:27163393
Serafimidis I et al. Pancreas lineage allocation and specification are regulated by sphingosine-1-phosphate signalling. 2017 PLoS Biol. pmid:28248965
Lee HM et al. Oncogenic S1P signalling in EBV-associated nasopharyngeal carcinoma activates AKT and promotes cell migration through S1P receptor 3. 2017 J. Pathol. pmid:28240350
Rieck M et al. Ceramide synthase 2 facilitates S1P-dependent egress of thymocytes into the circulation in mice. 2017 Eur. J. Immunol. pmid:28198542
Bruno M et al. Sphingosine 1-phosphate signaling axis mediates fibroblast growth factor 2-induced proliferation and survival of murine auditory neuroblasts. 2017 Biochim. Biophys. Acta pmid:28188805
Qi H et al. Analysis of sphingolipids in human corneal fibroblasts from normal and keratoconus patients. 2017 J. Lipid Res. pmid:28188148
Ren K et al. ApoA-I/SR-BI modulates S1P/S1PR2-mediated inflammation through the PI3K/Akt signaling pathway in HUVECs. 2017 J. Physiol. Biochem. pmid:28181168
Ruiz M et al. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium. 2017 Lipids Health Dis pmid:28179022
Moruno-Manchon JF et al. Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease. 2017 Hum. Mol. Genet. pmid:28175299
Rojas-Canales D et al. Local Sphingosine Kinase 1 Activity Improves Islet Transplantation. 2017 Diabetes pmid:28174291
Dela Paz NG et al. Shear stress induces Gα activation independently of G protein-coupled receptor activation in endothelial cells. 2017 Am. J. Physiol., Cell Physiol. pmid:28148497
Green CL et al. The effects of graded levels of calorie restriction: IX. Global metabolomic screen reveals modulation of carnitines, sphingolipids and bile acids in the liver of C57BL/6 mice. 2017 Aging Cell pmid:28139067
Vishwakarma S et al. Altered Expression of Sphingosine-1-Phosphate Metabolizing Enzymes in Oral Cancer Correlate With Clinicopathological Attributes. 2017 Cancer Invest. pmid:28135860